Larimar Therapeutics Inc
F:ZA71
Larimar Therapeutics Inc
F:ZA71
Price:
3.26
EUR
1.24%
Market Cap:
€208m
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently Viewed
|
L
|
Larimar Therapeutics Inc
F:ZA71
|
US |
|
Lindsay Corp
NYSE:LNN
|
US |
|
C
|
Crown International Corp Ltd
HKEX:727
|
HK |
|
C
|
Compagnie d'entreprises CFE SA
SWB:C70
|
BE |
|
La Francaise de l Energie SA
PAR:FDE
|
FR |
|
P
|
Paradigm Biopharmaceuticals Ltd
OTC:PBIGF
|
AU |
|
E
|
Enwave Corp
F:E4U
|
CA |
|
T
|
Texas Instruments Inc
XBER:TII
|
US |
|
L
|
Legrand SA
DUS:LRC
|
FR |
|
R S Software (India) Ltd
NSE:RSSOFTWARE
|
IN |
|
4
|
4Front Ventures Corp
CNSX:FFNT
|
US |
|
S
|
Salesforce Inc
SWB:FOO
|
US |
Multiples-Based Value
The Multiples-Based Value for 
Larimar Therapeutics Inc (ZA71) under the Base Case is hidden
EUR.
Compared with the current market price of 3.26 EUR, the stock appears hidden
.
Multiples-Based Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.
Relative Valuation FAQ:
ZA71 Multiples-Based Value
LOCKED
